Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Among older multimorbid patients, what are the rates of inappropriate vitamin D supplementation and risk factors of it?

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Multiple reported designs.

Multiple reported designs

More than one design is explicitly reported; examine the supporting methods.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

In this cross-sectional analysis of 2008 multimorbid older patients with polypharmacy, 41% received vitamin D supplementation, of which 10% did not belong to high-risk groups, representing potential overuse.

Source: Abstract.

Patients were recruited from hospital wards such as geriatrics, internal medicine, and surgery, with common diagnoses including cardiovascular diseases, diabetes, osteoporosis, fractures and others.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Inappropriate vitamin D supplementation among multimorbid older patients: a multicountry analysis

Multiple reported designs · BMC Geriatrics · 2025

Original publication title

Inappropriate vitamin D supplementation among multimorbid older patients: a multicountry analysis

Elisavet Moutzouri; Shanthi Beglinger; Martin Feller; Anne Eichenberger; Olivia Dalleur; Wilma Knol; Marielle Emmelot-Vonk; Denis O’Mahony; Benoit Boland; Carole E. Aubert; Patricia O. Chocano-Bedoya; Drahomir Aujesky; Anne Spinewine; Nicolas Rodondi

© The Author(s) 2025

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

One-third of multimorbid older adults experienced potential underuse, while up to 10% potential overuse of vitamin D supplementation. Polypharmacy, previous hospitalizations, increasing age and being male are factors associated with inappropriate use of vitamin D. A better targeted vitamin D supplementation is warranted.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

The prevalence of vitamin D supplementation and the percentage of participants with a lack of appropriate vitamin D supplementation (“potential underuse”) or potentially inappropriate vitamin D supplementation (“potential overuse”) and risk factors for these are currently unclear.

Source: Background

Abstract: What methods does the paper describe?

Cross-sectional analysis from the OPERAM study, a multicenter cluster randomized controlled trial in four European countries (Belgium, Ireland, The Netherlands, Switzerland) including multimorbid (≥ 3 chronic conditions) older patients, with polypharmacy (≥ 5 chronic medications). For the definition of potential underuse and overuse we used high-risk conditions, which were defined according to the START criteria (version 2) for potential prescribing omissions in older people i.e., E2) long-term systemic corticosteroid therapy, known osteoporosis or osteopenia, E3) previous fragility fractures, and E5) housebound/in nursing homes or experiencing falls.

We used mixed effect logistic regression to identify factors associated with underuse and overuse.

Source: Methods

Abstract: Question

Among older multimorbid patients, what are the rates of inappropriate vitamin D supplementation and risk factors of it?

Source: Question

Abstract: Meaning

These findings show considerable vitamin D treatment variations with evidence of inappropriate use in multimorbid older people. The uncertain data regarding the clinical impacts of vitamin D may be the reason for these results. A better targeted prescription of vitamin D supplementation is warranted.

Source: Meaning

Abstract: Results

2008 patients (79.4y, SD 6.3, 45% female) were included. 825/2008 (41.1%) were supplemented with vitamin D. We identified 681 participants with potential underuse (33.9% of all participants, 69.7% of non-vitamin D users) and 204 with potential overuse (10.2% of all participants, 24.7% of vitamin D users). In the multivariable logistic regression analysis increasing age and being male were associated with underuse, while the number of baseline medications and previous hospitalizations were associated with both underuse and overuse. Specifically, underuse decreased with an increasing number of medications (OR: 0.93, 95% CI: 0.90 to 0.95), while overuse increased (OR: 1.08, 95% CI: 1.04 to 1.12).

Previous hospitalizations were linked to underuse (OR: 1.08, 95% CI: 1.00-1.17) and inversely associated with overuse (OR: 0.88, 95% CI: 0.77 to 0.99).

Source: Results

Abstract: Conclusions

One-third of multimorbid older adults experienced potential underuse, while up to 10% potential overuse of vitamin D supplementation. Polypharmacy, previous hospitalizations, increasing age and being male are factors associated with inappropriate use of vitamin D. A better targeted vitamin D supplementation is warranted.

Source: Conclusions
Authors’ abstract

Background

The prevalence of vitamin D supplementation and the percentage of participants with a lack of appropriate vitamin D supplementation (“potential underuse”) or potentially inappropriate vitamin D supplementation (“potential overuse”) and risk factors for these are currently unclear.

Methods

Cross-sectional analysis from the OPERAM study, a multicenter cluster randomized controlled trial in four European countries (Belgium, Ireland, The Netherlands, Switzerland) including multimorbid (≥ 3 chronic conditions) older patients, with polypharmacy (≥ 5 chronic medications). For the definition of potential underuse and overuse we used high-risk conditions, which were defined according to the START criteria (version 2) for potential prescribing omissions in older people i.e., E2) long-term systemic corticosteroid therapy, known osteoporosis or osteopenia, E3) previous fragility fractures, and E5) housebound/in nursing homes or experiencing falls.

We used mixed effect logistic regression to identify factors associated with underuse and overuse.

Results

2008 patients (79.4y, SD 6.3, 45% female) were included. 825/2008 (41.1%) were supplemented with vitamin D. We identified 681 participants with potential underuse (33.9% of all participants, 69.7% of non-vitamin D users) and 204 with potential overuse (10.2% of all participants, 24.7% of vitamin D users). In the multivariable logistic regression analysis increasing age and being male were associated with underuse, while the number of baseline medications and previous hospitalizations were associated with both underuse and overuse. Specifically, underuse decreased with an increasing number of medications (OR: 0.93, 95% CI: 0.90 to 0.95), while overuse increased (OR: 1.08, 95% CI: 1.04 to 1.12).

Previous hospitalizations were linked to underuse (OR: 1.08, 95% CI: 1.00-1.17) and inversely associated with overuse (OR: 0.88, 95% CI: 0.77 to 0.99).

Conclusions

One-third of multimorbid older adults experienced potential underuse, while up to 10% potential overuse of vitamin D supplementation. Polypharmacy, previous hospitalizations, increasing age and being male are factors associated with inappropriate use of vitamin D. A better targeted vitamin D supplementation is warranted.

Trial registration

NCT02986425, Registration date 2016-10-21.

Key Points

Question

Among older multimorbid patients, what are the rates of inappropriate vitamin D supplementation and risk factors of it?

Findings

In this cross-sectional analysis of 2008 multimorbid older patients with polypharmacy, 41% received vitamin D supplementation, of which 10% did not belong to high-risk groups, representing potential overuse. A further 34% of all participants were not receiving vitamin D, although belonging to high-risk groups, i.e. representing potential underuse. In multivariable analyses specific risk factors for underuse or overuse of vitamin D were identified: polypharmacy, hospitalizations, age and sex.

Meaning

These findings show considerable vitamin D treatment variations with evidence of inappropriate use in multimorbid older people. The uncertain data regarding the clinical impacts of vitamin D may be the reason for these results. A better targeted prescription of vitamin D supplementation is warranted.

Publication and source details

Original title: Inappropriate vitamin D supplementation among multimorbid older patients: a multicountry analysis

Elisavet Moutzouri; Shanthi Beglinger; Martin Feller; Anne Eichenberger; Olivia Dalleur; Wilma Knol; Marielle Emmelot-Vonk; Denis O’Mahony; Benoit Boland; Carole E. Aubert; Patricia O. Chocano-Bedoya; Drahomir Aujesky; Anne Spinewine; Nicolas Rodondi

BMC Geriatrics · 2025

© The Author(s) 20252025https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.Kollegium of Hausarzt Medizinhttp://dx.doi.org/10.13039/501100001711Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen ForschungPZ00P3_201672Aubert Carole E.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T01:25:19.833418+00:00

DOI: 10.1186/s12877-025-06189-w · PMC12275266